The Cambridge BRC has a pioneering experimental research programme in dementia centred around the Cambridge Dementia Biomedical Research Unit (BRU) and the Dementia and Neurodegeneration Research Theme. The programme capitalizes upon unique, world-leading research in the laboratory through to patient trials in clinics and arises from the work of a collaborative group of internationally-recognized researchers who use innovative application of physical, biological and medical sciences to the problem of dementia.
The Cambridge Dementia team is part of the overall Cambridge BRC which has relevant links in genomics, population science, imaging, cell, molecular and developmental biology, and regenerative medicine. The highly collaborative nature of this integrated bench to bedside research programme underpins its unique ability to expediate the rapid and effective translations of new preclinical discoveries into successful products that will significantly impact on the diagnosis, prevention and treatment of dementia for both the individual patient and the community.
To read more about our research objectives and aims and to find contact details of prinicipal investigators please follow the links on the left.
Professor Peter St George-Hyslop, Director of the Cambridge Dementia Biomedical Research Unit
Professor Roger Barker, Theme lead for the Dementia and Neurodegenerative Disorders Theme